Natixis Lantheus Holdings, Inc. Transaction History

Natixis

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$58.87 - $83.05 $352,866 - $497,801	-5,994 Reduced 28.63%	14,943 $1.2 Million
Q1 2024 May 13, 2024	BUY	$51.07 - $68.26 $455,544 - $608,879	8,920 Added 74.23%	20,937 $1.3 Million
Q4 2023 Feb 13, 2024	BUY	$55.6 - $77.89 $668,145 - $936,004	12,017 New	12,017 $745,000
Q1 2023 May 12, 2023	SELL	$47.76 - $82.86 $24,691 - $42,838	-517 Reduced 2.9%	17,330 $1.43 Million
Q4 2022 Feb 13, 2023	SELL	$48.76 - $77.67 $31,255 - $49,786	-641 Reduced 3.47%	17,847 $909,000
Q3 2022 Nov 14, 2022	SELL	$61.42 - $86.29 $49,811 - $69,981	-811 Reduced 4.2%	18,488 $1.34 Million
Q2 2022 Aug 12, 2022	BUY	$55.54 - $72.65 $1.07 Million - $1.4 Million	19,299 New	19,299 $1.25 Million

542

68M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.29B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.